• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化中的炎症及其解决:介质和治疗机会。

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.

机构信息

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.

Columbia University Irving Medical Center, New York, NY, USA.

出版信息

Nat Rev Cardiol. 2019 Jul;16(7):389-406. doi: 10.1038/s41569-019-0169-2.

DOI:10.1038/s41569-019-0169-2
PMID:30846875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6727648/
Abstract

Atherosclerosis is a lipid-driven inflammatory disease of the arterial intima in which the balance of pro-inflammatory and inflammation-resolving mechanisms dictates the final clinical outcome. Intimal infiltration and modification of plasma-derived lipoproteins and their uptake mainly by macrophages, with ensuing formation of lipid-filled foam cells, initiate atherosclerotic lesion formation, and deficient efferocytotic removal of apoptotic cells and foam cells sustains lesion progression. Defective efferocytosis, as a sign of inadequate inflammation resolution, leads to accumulation of secondarily necrotic macrophages and foam cells and the formation of an advanced lesion with a necrotic lipid core, indicative of plaque vulnerability. Resolution of inflammation is mediated by specialized pro-resolving lipid mediators derived from omega-3 fatty acids or arachidonic acid and by relevant proteins and signalling gaseous molecules. One of the major effects of inflammation resolution mediators is phenotypic conversion of pro-inflammatory macrophages into macrophages that suppress inflammation and promote healing. In advanced atherosclerotic lesions, the ratio between specialized pro-resolving mediators and pro-inflammatory lipids (in particular leukotrienes) is strikingly low, providing a molecular explanation for the defective inflammation resolution features of these lesions. In this Review, we discuss the mechanisms of the formation of clinically dangerous atherosclerotic lesions and the potential of pro-resolving mediator therapy to inhibit this process.

摘要

动脉粥样硬化是一种以动脉内膜为靶器官的脂质驱动的炎症性疾病,其中促炎和抗炎机制的平衡决定了最终的临床结局。内膜浸润和血浆来源的脂蛋白的修饰及其被巨噬细胞摄取,随后形成充满脂质的泡沫细胞,启动动脉粥样硬化病变的形成,而凋亡细胞和泡沫细胞的吞噬作用不足则持续促进病变进展。吞噬作用的缺陷,作为炎症消退不足的标志,导致继发性坏死的巨噬细胞和泡沫细胞的积累,并形成一个具有坏死脂质核心的晚期病变,表明斑块的脆弱性。炎症的消退是由来源于ω-3 脂肪酸或花生四烯酸的专门的促解决脂类介质以及相关蛋白和信号气态分子介导的。炎症消退介质的主要作用之一是将促炎巨噬细胞转化为抑制炎症和促进愈合的巨噬细胞。在晚期动脉粥样硬化病变中,专门的促解决介质与促炎脂质(特别是白三烯)之间的比例明显较低,为这些病变中吞噬作用缺陷的炎症消退特征提供了分子解释。在这篇综述中,我们讨论了临床上危险的动脉粥样硬化病变形成的机制以及促解决介质治疗抑制这一过程的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/6a643359c2d7/nihms-1048780-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/cdbf6c256dad/nihms-1048780-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/c0127ff89340/nihms-1048780-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/52f4e5b95c1c/nihms-1048780-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/1f0d416cfcd5/nihms-1048780-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/6a643359c2d7/nihms-1048780-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/cdbf6c256dad/nihms-1048780-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/c0127ff89340/nihms-1048780-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/52f4e5b95c1c/nihms-1048780-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/1f0d416cfcd5/nihms-1048780-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1846/6727648/6a643359c2d7/nihms-1048780-f0005.jpg

相似文献

1
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.动脉粥样硬化中的炎症及其解决:介质和治疗机会。
Nat Rev Cardiol. 2019 Jul;16(7):389-406. doi: 10.1038/s41569-019-0169-2.
2
Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.动脉粥样硬化病变中的噬斑细胞清除作用:功能失调的调节途径和控制机制。
Pharmacol Ther. 2018 Aug;188:12-25. doi: 10.1016/j.pharmthera.2018.02.003. Epub 2018 Feb 11.
3
The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification.通过ω-3 脂肪酸在动脉粥样硬化、内膜增生和血管钙化中解决炎症问题。
Semin Immunopathol. 2019 Nov;41(6):757-766. doi: 10.1007/s00281-019-00767-y. Epub 2019 Nov 6.
4
The role of non-resolving inflammation in atherosclerosis.非解决性炎症在动脉粥样硬化中的作用。
J Clin Invest. 2018 Jul 2;128(7):2713-2723. doi: 10.1172/JCI97950.
5
Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis.动脉粥样硬化中吞噬功能缺陷的机制及后果
Front Cardiovasc Med. 2018 Jan 8;4:86. doi: 10.3389/fcvm.2017.00086. eCollection 2017.
6
Role of NLRP3 Inflammasomes in Atherosclerosis.NLRP3炎性小体在动脉粥样硬化中的作用。
J Atheroscler Thromb. 2017 May 1;24(5):443-451. doi: 10.5551/jat.RV17001. Epub 2017 Mar 4.
7
Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice.解决脂质介质maresin 1 和 resolvin D2 可预防小鼠动脉粥样硬化进展。
Circ Res. 2016 Oct 14;119(9):1030-1038. doi: 10.1161/CIRCRESAHA.116.309492. Epub 2016 Aug 16.
8
ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.ERV1/ChemR23 信号通过调节巨噬细胞对氧化型低密度脂蛋白的摄取和吞噬作用来保护动脉粥样硬化。
Circulation. 2018 Oct 16;138(16):1693-1705. doi: 10.1161/CIRCULATIONAHA.117.032801.
9
Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study.人类冠状动脉中动脉粥样硬化从病理性内膜增厚到晚期纤维粥样瘤的自然进展:一项病理学研究。
Atherosclerosis. 2015 Aug;241(2):772-82. doi: 10.1016/j.atherosclerosis.2015.05.011. Epub 2015 May 19.
10
Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.前沿科学:特异性促解决脂质介质抑制巨噬细胞 NLRP3 炎性体的启动和激活。
J Leukoc Biol. 2019 Jan;105(1):25-36. doi: 10.1002/JLB.3HI0517-206RR. Epub 2018 Mar 30.

引用本文的文献

1
The alarmin tandem: unraveling the complex effect of S100A8/A9 - from atherosclerosis to cardiac arrhythmias.警报素串联:揭示S100A8/A9的复杂作用——从动脉粥样硬化到心律失常
Front Immunol. 2025 Aug 28;16:1630410. doi: 10.3389/fimmu.2025.1630410. eCollection 2025.
2
The Relationship Between C-Reactive Protein-Triacylglycerol-Glucose Index and All-Cause Mortality in Patients With Cardiovascular Disease: A Retrospective Cohort Study and Development of a Machine Learning Prediction Model.心血管疾病患者中C反应蛋白-三酰甘油-葡萄糖指数与全因死亡率的关系:一项回顾性队列研究及机器学习预测模型的开发
Cardiovasc Ther. 2025 Sep 3;2025:6914985. doi: 10.1155/cdr/6914985. eCollection 2025.
3

本文引用的文献

1
Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms.通过脂氧素和ALX/FPR2受体途径消退炎症可预防腹主动脉瘤。
JACC Basic Transl Sci. 2018 Dec 31;3(6):719-727. doi: 10.1016/j.jacbts.2018.08.005. eCollection 2018 Dec.
2
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.依泽替米贝降低严重高甘油三酯血症患者心血管风险
N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.
3
Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models.
Oral targeting tilianin nanoplatform mitigates atherosclerosis through promoting macrophage phagocytosis and anti-inflammation.
口服靶向田基黄苷纳米平台通过促进巨噬细胞吞噬作用和抗炎作用减轻动脉粥样硬化。
Mater Today Bio. 2025 Aug 16;34:102204. doi: 10.1016/j.mtbio.2025.102204. eCollection 2025 Oct.
4
Epigenetic‑ncRNA crosstalk in atherosclerosis: Mechanisms, disease progression and therapeutic potential (Review).动脉粥样硬化中的表观遗传 - 非编码RNA相互作用:机制、疾病进展及治疗潜力(综述)
Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5621. Epub 2025 Sep 5.
5
Nonlinear associations between the aggregate index of systemic inflammation and cardiovascular disease in adults: evidence from NHANES 2011-2020.成人全身炎症综合指数与心血管疾病之间的非线性关联:来自2011 - 2020年美国国家健康与营养检查调查(NHANES)的证据
BMC Public Health. 2025 Sep 2;25(1):3031. doi: 10.1186/s12889-025-24320-9.
6
Advancements in macrophage research for cardiovascular disease.巨噬细胞在心血管疾病研究中的进展。
Front Physiol. 2025 Aug 14;16:1647865. doi: 10.3389/fphys.2025.1647865. eCollection 2025.
7
Enhancing the efficacy of sonodynamic therapy through modulation of autophagy.通过调节自噬提高声动力疗法的疗效。
Ultrason Sonochem. 2025 Aug 25;121:107527. doi: 10.1016/j.ultsonch.2025.107527.
8
Correlation between the neutrophil-to-lymphocyte ratio with the severity of new-onset coronary artery disease in various glucose metabolic states: a retrospective study.不同糖代谢状态下中性粒细胞与淋巴细胞比值与新发冠状动脉疾病严重程度的相关性:一项回顾性研究
BMC Cardiovasc Disord. 2025 Aug 29;25(1):642. doi: 10.1186/s12872-025-05111-x.
9
[Multiple comorbidities with migraine-Is there a common cause?].[偏头痛的多种合并症——是否存在共同病因?]
Schmerz. 2025 Aug 28. doi: 10.1007/s00482-025-00901-w.
10
Significant Interplay Between Lipids, Cytokines, Chemokines, Growth Factors, and Blood Cells in an Outpatient Cohort.门诊队列中脂质、细胞因子、趋化因子、生长因子与血细胞之间的显著相互作用
Int J Mol Sci. 2025 Aug 11;26(16):7746. doi: 10.3390/ijms26167746.
转录组分析揭示了动脉粥样硬化小鼠模型中促炎的是非泡沫斑块巨噬细胞,而不是泡沫斑块巨噬细胞。
Circ Res. 2018 Oct 26;123(10):1127-1142. doi: 10.1161/CIRCRESAHA.118.312804.
4
Role of Allergic Inflammatory Cells in Coronary Artery Disease.过敏性炎症细胞在冠状动脉疾病中的作用。
Circulation. 2018 Oct 16;138(16):1736-1748. doi: 10.1161/CIRCULATIONAHA.118.035400.
5
The atheroprotective role of lipoxin A prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway.脂氧素 A 的抗动脉粥样硬化作用通过 JNK 通路防止 oxLDL 诱导的巨噬细胞凋亡信号。
Atherosclerosis. 2018 Nov;278:259-268. doi: 10.1016/j.atherosclerosis.2018.09.025. Epub 2018 Sep 28.
6
Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution.调节性 T 细胞促进炎症消退期巨噬细胞的胞葬作用。
Immunity. 2018 Oct 16;49(4):666-677.e6. doi: 10.1016/j.immuni.2018.07.015. Epub 2018 Oct 2.
7
MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity.MerTK 信号在巨噬细胞中通过抑制 CaMKII 活性促进炎症解决介质的合成。
Sci Signal. 2018 Sep 25;11(549):eaar3721. doi: 10.1126/scisignal.aar3721.
8
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.糖尿病患者的 n-3 脂肪酸补充效果。
N Engl J Med. 2018 Oct 18;379(16):1540-1550. doi: 10.1056/NEJMoa1804989. Epub 2018 Aug 26.
9
The role of non-resolving inflammation in atherosclerosis.非解决性炎症在动脉粥样硬化中的作用。
J Clin Invest. 2018 Jul 2;128(7):2713-2723. doi: 10.1172/JCI97950.
10
Atherosclerosis in the single-cell era.单细胞时代的动脉粥样硬化。
Curr Opin Lipidol. 2018 Oct;29(5):389-396. doi: 10.1097/MOL.0000000000000537.